GLI1 and breast carcinoma: Additionally, targeting GLI1 as a key gene may facilitate the screening of effective therapeutic agents (An et al., 2021), contributing to the advancement of personalized treatment approaches for breast cancer and promoting relevant clinical trials for combination immunotherapy.